Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
No significant difference was found in BMI, ALT, Cr, sCa, sPi, P1NP, CTX, 25OHD and PTH between two groups (P > 0.05) (Table 1).Demographic data and laboratory indicators in NBG and ABG group (x ± s)TotalNBGABGP value138 (100%)97 (70.3%)41 (29.7%)Age70.67 ± 12.3268.80 ± 12.4075.09 ± 11.080.006*BMI (kg/m2)24.55 ± 3.2124.41 ± 3.1924.87 ± 3.260.444ALT (U/L)19.12 ± 8.7318.57 ± 8.0520.44 ± 10.160.251Cr (μmol/L)79.85 ± 13.9878.70 ± 13.9482.56 ± 13.890.139sCa (mmol/L)2.36 ± 0.082.36 ± 0.082.36 ± 0.080.962sPi (mmol/L)1.05 ± 0.121.05 ± 0.101.05 ± 0.150.837FPG (mmol/L)6 ± 15.79 ± 0.896.51 ± 1.080.000*HbA1c (%)6.03 ± 0.625.85 ± 0.456.50 ± 0.910.000*P1NP (ng/mL)33.07 ± 11.4330.18 ± 10.3435.41 ± 12.060.227CTX (ng/mL)0.31 ± 0.20.26 ± 0.120.30 ± 0.250.22725OHD (ng/mL)22.83 ± 10.2420.79 ± 6.8922.48 ± 12.290.343PTH (pg/mL)42.15 ± 13.6342.13 ± 14.6139.86 ± 12.800.302Notes: All *P < 0.05Abbreviations: NBG Normal blood glucose group; ABG Abnormal blood glucose group; BMI Body mass index; ALT Glutamic-pyruvic transaminase; Cr Creatinine; sCa Serum Calcium; sPi Serum inorganic Phosphorus; FPG Fasting blood glucose; HbA1c Glycated hemoglobin; P1NP Amino-terminal propeptide of type 1 collagen; CTX Cross linked C telopeptide of type 1 collagen; 25OHD 25-hydroxy vitamin D; PTH Parathyroid hormone
Source: Demographic data in middle-aged and elderly men with NBG or ABG. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Total 138 men aged above 50 years old with routine physical examination were involved in the study.
Source: Abstract.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
The study of bone mineral density measured by quantitative computed tomography in middle-aged and elderly men with abnormal glucose metabolism
Study design awaiting verification · BMC Endocrine Disorders · 2022
Original publication title
The study of bone mineral density measured by quantitative computed tomography in middle-aged and elderly men with abnormal glucose metabolism
© The Author(s) 2022
Original publication · Publisher record · CC BY 4.0 · CC0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
To investigate the value of quantitative computed tomography (QCT) measurement of bone mineral density (BMD) in middle-aged and elderly men with abnormal blood glucose.
Source: BackgroundAbstract: What methods does the paper describe?
Total 138 men aged above 50 years old with routine physical examination were involved in the study. All participants were evaluated with serological index, BMD by QCT and dual energy X-ray absorptiometry (DXA). Statistical analysis was conducted by χ2 test and regression model.
Source: MethodsAbstract: Results
All individuals were divided into normal blood glucose (NBG) group and abnormal blood glucose (ABG) group. Compared with NBG group, BMD detected by QCT was obviously lower in ABG group (P < 0.05). More cases with low bone mass or osteoporosis were detected by QCT measurement than DXA (χ2 = 56.618, P = 0.000), which were consistent in both NBG and ABG groups (χ2 was 33.564 and 23.250, P = 0.000). No significant difference of detection rates was found in both subgroups neither by QCT nor DXA measurement (χ2 = 4.204, P = 0.122).
Regression analysis revealed that ABG was negatively associated with BMD assessed by QCT (β = -0.217, P < 0.05), which did not show statistical difference after adjusting for age.
Source: ResultsAbstract: Conclusion
In middle-aged and elderly male patients with NBG or ABG, QCT manifests higher detection rates of low bone mass and osteoporosis than DXA. ABG is negatively correlated with BMD measured by QCT, which is affected by age.
Source: ConclusionAuthors’ abstract
Background
To investigate the value of quantitative computed tomography (QCT) measurement of bone mineral density (BMD) in middle-aged and elderly men with abnormal blood glucose.
Methods
Total 138 men aged above 50 years old with routine physical examination were involved in the study. All participants were evaluated with serological index, BMD by QCT and dual energy X-ray absorptiometry (DXA). Statistical analysis was conducted by χ2 test and regression model.
Results
All individuals were divided into normal blood glucose (NBG) group and abnormal blood glucose (ABG) group. Compared with NBG group, BMD detected by QCT was obviously lower in ABG group (P < 0.05). More cases with low bone mass or osteoporosis were detected by QCT measurement than DXA (χ2 = 56.618, P = 0.000), which were consistent in both NBG and ABG groups (χ2 was 33.564 and 23.250, P = 0.000). No significant difference of detection rates was found in both subgroups neither by QCT nor DXA measurement (χ2 = 4.204, P = 0.122).
Regression analysis revealed that ABG was negatively associated with BMD assessed by QCT (β = -0.217, P < 0.05), which did not show statistical difference after adjusting for age.
Conclusion
In middle-aged and elderly male patients with NBG or ABG, QCT manifests higher detection rates of low bone mass and osteoporosis than DXA. ABG is negatively correlated with BMD measured by QCT, which is affected by age.
Publication and source details
Original title: The study of bone mineral density measured by quantitative computed tomography in middle-aged and elderly men with abnormal glucose metabolism
Pei Zhang; Xiaofeng Huang; Yanping Gong; Yanhui Lu; Minyan Liu; Xiaoling Cheng; Nan Li; Chunlin Li
BMC Endocrine Disorders · 2022
© The Author(s) 2022https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.http://dx.doi.org/10.13039/501100012166National Key Research and Development Program of China2020YFC20049002020YFC20049002020YFC20049002020YFC20049002020YFC20049002020YFC20049002020YFC20049002020YFC2004900Zhang Pei Huang Xiaofeng Gong Yanping Lu Yanhui Liu Minyan Cheng Xiaoling Li Nan Li Chunlin Top Scientific Research Project of Second Medical Center of Chinese PLA General HospitalZXBJ2003ZXBJ2003ZXBJ2003ZXBJ2003ZXBJ2003ZXBJ2003ZXBJ2003ZXBJ2003Zhang Pei Huang Xiaofeng Gong Yanping Lu Yanhui Liu Minyan Cheng Xiaoling Li Nan Li ChunlinRepository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T08:37:14.475118+00:00
DOI: 10.1186/s12902-022-01076-6 · PMC9264566